Research advances toward more effective, long-lasting and side effect-free cancer treatments The Baylor team is building the case for SRC-3 as a promising therapeutic target for next-generation cancer immunotherapy.

Drs. Sang Jun Han, D. Lonard et al are building the case for #SRC3 as a promising #therapeuticTarget for next-generation #cancer #immunotherapy. #Oncoimmunology @tandfonline.bsky.social @bcmhouston.bsky.social #BCMCancerCenter #HotTumor #ColdTumor blogs.bcm.edu/2026/03/26/f...

#oncoimmunology
#microbiota

Cancer drugs called immune bottleneck inhibitors are remarkably efficient, but only in some patients.

Transplants of their feces in mice show that the difference is due to a strain of Hominenteromicrobium mulieris, a bacterium first isolated in woman's gut 2 years ago.

Under the brain tumor spell Reading time: 5 minutes Mariella Careaga Glioblastoma is a highly aggressive form of cancer that accounts for nearly half of all primary malignant brain tumors in adults (1). Patients diagnosed wit…

Researchers have deciphered how tumor-associated macrophages communicate with brain tumor cells. This leads insight into what fuels #glioblastoma progression, opening new promising avenues for treating this deadly brain tumor. Mariella Careaga writes.
#oncoimmunology

oncobites.blog/2025/04/23/u...

Trial watch: anticancer vaccination with dendritic cells: OncoImmunology: Vol 13, No 1 We’re here to help

#Trial #watch: #anticancer #vaccination with #dendritic #cells: #OncoImmunology www.tandfonline.com/doi/metrics/...